Based on a group of relevant investigations, miR-7-5p has some remarkable tumor-suppressive impacts on GBM by modulating the EGFR, Raf/MEK/ERK, and PI3K/AKT signaling pathways [153, 154]. The gene discussed is EGFR; the disease is glioblastoma.